Please Note: Microsoft has ended support of its older browsers as of January 2016. If you are seeing this message, you are viewing the site on an unsupported version of Internet Explorer (IE10 or older). To properly view this website, please upgrade your version of IE or access this site using a different browser. Thank you.
Sign InDues Join Privacy Contact Search
Home News Scrip

Scrip

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below.

John Lezcano
Corporate Account Manager
M: (631) 807-4971
John.lezcano@informa.com

Pharma intelligence | informa
P: (212) 652-2678
pharmaintelligence.informa.com

Scrip
Saturday, September 19, 2020
Data show Opdivo/Cabometyx combo bests Sutent for overall and progression-free survival and response endpoints in first-line RCC. Exelixis CEO says...
Friday, September 18, 2020
ES: Public Company Edition: Fifty biopharma companies launched initial public offerings in the US last year and there have been...
Friday, September 18, 2020
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies...
Friday, September 18, 2020
A composite endpoint conceals Actemra’s lack of mortality benefit – while life-saving dexamethasone gets EMA endorsement.
Around the world, government agencies, academic and other researchers and the biopharmaceutical industry have rushed to see what drugs could...
       
Friday, September 18, 2020
Moderna led by releasing the trial protocol for its COVID-19 vaccine study, followed by Pfizer, as industry faces demands for...
Friday, September 18, 2020
Japanese ophthalmic specialist picks up young private US firm and gains a small but broad set of marketed products.  
Thursday, September 17, 2020
The coronavirus pandemic hurt the German group's healthcare division but helped the contract development and manufacturing activities of Merck's life...
Thursday, September 17, 2020
Cancer deals involving Junshi/Wigen, Allist/Octimet, Yufan/Abound, Takeda/Presage, Daiichi Sankyo/AnHeart, LegoChem/Harbour Biomed, plus a stem cell partnership and a lysosomal storage...
Thursday, September 17, 2020
The world is waiting for Moderna’s COVID-19 vaccine results, but meanwhile the company is exploring new avenues to secure long-term...